
eMDI for Patients with Asthma and COPD
By H&T Presspart
H&T Presspart and Cohero Health are currently collaborating with pharmaceutical manufacturers who are leveraging the technology for pipeline development and value-added product differentiation.
As a fully functioning, market-ready device, it will enable pharmaceutical manufacturers the best possible care to patients with asthma and COPD quickly and in a cost-effective manner.
Download this free whitepaper to find out more.
